U.S. Markets closed

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
4.29+0.02 (+0.47%)
At close: 3:59PM EDT
People also watch

Tonix Pharmaceuticals Holding Corp.

509 Madison Avenue
Suite 306
New York, NY 10022
United States

IndustryDrug Manufacturers - Major
Full Time Employees18

Key Executives

Dr. Seth Lederman M.D.Co-Founder, Chairman, Chief Exec. Officer, Pres472.5kN/A59
Dr. Donald W. Landry M.D., Ph.D.Co-Founder and Director45.75kN/A62
Mr. Bradley Saenger CPAChief Financial Officer and Treasurer301.36kN/A43
Dr. Gregory M. Sullivan M.D.Chief Medical Officer and Sec.335kN/A51
Mrs. Jessica Edgar MorrisExec. VP of OperationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Tonix Pharmaceuticals Holding Corp., a clinical-stage pharmaceutical company, engages in developing pharmaceutical products for central nervous system disorders. The company’s lead program focuses on post-traumatic stress disorder (PTSD) that is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. Its lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet, which is in Phase III clinical stage for the treatment of PTSD; and Phase III clinical stage for the treatment of military-related PTSD. The company’s product candidates also include TNX-601, an oral formulation of tianeptine oxalate for PTSD and cognitive dysfunction associated with steroid use; TNX-801, a smallpox-preventing vaccine based on a live synthetic version of horsepox virus; TNX-301, a fixed-dose combination drug product for alcohol use disorders; and TNX-701 for radiation injuries. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in New York, New York.

Corporate Governance

Tonix Pharmaceuticals Holding Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.